Infection and Drug Resistance
Volume 15, 2022 - Issue
Open access
112
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT
Clinical Implication of the Effect of the Production of Neutralizing Antibodies Against SARS-Cov-2 for Chronic Immune Thrombocytopenia Flare-Up Associated with COVID-19 Infection: A Case Report and the Review of Literature
Chika Maekura1 Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
, Ayako Muramatsu1 Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
, Hiroaki Nagata1 Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
, Haruya Okamoto1 Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
, Akio Onishi1 Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
, Daishi Kato1 Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
, Reiko Isa1 Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
, Takahiro Fujino1 Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japanhttps://orcid.org/0000-0001-7817-093X
, Taku Tsukamoto1 Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
, Shinsuke Mizutani1 Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
, Yuji Shimura1 Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan;2 Department of Blood Transfusion, University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japanhttps://orcid.org/0000-0001-9309-7902
, Tsutomu Kobayashi1 Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japanhttps://orcid.org/0000-0002-5600-5762
, Keita Okumura3 Faculty of Clinical Laboratory, University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japanhttps://orcid.org/0000-0002-8422-8955
, Tohru Inaba4 Department of Infection Control & Laboratory Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japanhttps://orcid.org/0000-0002-1595-8524
, Yoko Nukui4 Department of Infection Control & Laboratory Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
& Junya Kuroda1 Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, JapanCorrespondence[email protected]
https://orcid.org/0000-0001-6130-1550
show allhttps://orcid.org/0000-0001-6130-1550
Pages 2723-2728
|
Published online: 31 May 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.